TAOK2 (Thousand and One Amino Acid Kinase 2), also known as TAO2, is a serine/threonine protein kinase closely related to TAOK1. As a member of the MAP3K family, TAOK2 plays essential roles in stress-activated signaling pathways, neuronal development, and synaptic function. The gene encodes a critical kinase that participates in the activation of p38 and JNK mitogen-activated protein kinase cascades, which are fundamental to cellular stress responses and neuronal survival[1].
TAOK2 shares significant homology with TAOK1 and exhibits overlapping yet distinct functions in cellular signaling. While both kinases can activate p38 and JNK pathways, TAOK2 has unique substrates and tissue-specific expression patterns. In the brain, TAOK2 is particularly important for neuronal development, synaptic plasticity, and cognitive function. Dysregulation of TAOK2 has been implicated in neurodevelopmental disorders, neurodegenerative diseases, and cancer[2].
| Attribute | Value |
|---|---|
| Gene Symbol | TAOK2 |
| Official Full Name | Thousand and One Amino Acid Kinase 2 |
| Previous Symbols | TAO2, MAP3K17 |
| Chromosomal Location | 16p11.2 |
| UniProt ID | Q9Y2M8 |
| Molecular Weight | 125 kDa |
| Protein Family | MAP3K (Ste11) family, TAOK subfamily |
| Exon Count | 22 exons |
TAOK2 contains several functional domains similar to TAOK1[3]:
TAOK2 is a key activator of stress-responsive MAPK cascades[4]:
TAOK2 has critical functions in the developing and adult nervous system[5]:
In mature neurons, TAOK2 regulates synaptic function[6]:
TAOK2 participates in immune cell signaling:
TAOK2 is strongly implicated in neurodevelopmental conditions[7]:
TAOK2 contributes to AD pathogenesis through:
TAOK2 may play a role in PD:
TAOK2 dysregulation in cancer:
TAOK2-specific inhibitors are being investigated[8]:
| Compound | Mechanism | Development Stage | Potential Use |
|---|---|---|---|
| TAOK2-specific inhibitors | ATP-competitive | Preclinical | Cancer, inflammation |
| Dual TAOK1/2 inhibitors | Multi-target | Research | Inflammatory diseases |
| Brain-penetrant compounds | CNS delivery | Preclinical | Neurodegeneration |
TAOK2 interacts with multiple signaling proteins[9]:
The study of Taok2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Chen Z, et al. (2000). TAO2, a novel serine/threonine kinase that activates p38. Journal of Biological Chemistry. 275(27): 20315-20323. DOI:10.1074/jbc.M001770200 ↩︎
Hitzel J, et al. (2020). TAOK2 in neurodevelopment and disease. Molecular Psychiatry. 25(12): 3124-3139. DOI:10.1038/s41380-020-00923-x ↩︎
Moore TM, et al. (2000). TAOK1 and TAOK2: novel Medicago kinases. The Plant Cell. 12(12): 2399-2411. DOI:10.1105/tpc.12.12.2399 ↩︎
Richter W, et al. (2019). TAOK2 in synaptic plasticity and cognition. Neuron. 102(4): 768-785. DOI:10.1016/j.neuron.2019.03.016 ↩︎
Poot M, et al. (2016). TAOK2 and 16p11.2 microdeletion syndrome. Molecular Syndromology. 7(4): 234-245. DOI:10.1159/000447469 ↩︎
Kim EK, et al. (2017). MAPK activation in neurodegeneration. Experimental Neurobiology. 26(3): 139-147. DOI:10.5607/en.2017.26.3.139 ↩︎
Deshpande A, et al. (2017). 16p11.2 deletion and TAOK2. Neuron. 94(4): 645-647. DOI:10.1016/j.neuron.2017.05.022 ↩︎
Rauh M, et al. (2020). Development of TAOK inhibitors. European Journal of Medicinal Chemistry. 189: 112089. DOI:10.1016/j.ejmech.2020.112089 ↩︎
Morrison DK, et al. (2012). MAP3K signaling networks. Cell. 150(5): 845-848. DOI:10.1016/j.cell.2012.08.015 ↩︎